cobimetinib,atezolizumab,vemurafenib
exelixis,merck,roche
['melanoma']
median os ~13 mos. we still have a long way to go for #melanoma brain metastases. #asco22 
Melanoma+Cell Therapy Oncologist @MSKCancerCenter| Cornell/DukeMed/ MGH IM/MSKCC Onc alum | FCOI: https://t.co/kwtet64Pe4